Teva poaches Vertex exec as new head of R&D
pharmaphorum
JULY 4, 2022
At Teva , he replaces Hafrun Fridriksdottir, a 25-year Teva veteran who was named R&D chief almost immediately after Kare Schultz took over the reins of Teva in 2017 with the task of turning around the fortunes of the ailing generics giant. He will be based out of Teva’s US headquarters in Parsippany, New Jersey.
Let's personalize your content